Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

812 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seronegative spondyloarthritides.
Olivieri I, van Tubergen A, Salvarani C, van der Linden S. Olivieri I, et al. Among authors: salvarani c. Best Pract Res Clin Rheumatol. 2002 Dec;16(5):723-39. doi: 10.1053/berh.2002.0263. Best Pract Res Clin Rheumatol. 2002. PMID: 12473270 Review.
Efficacy of infliximab in resistant psoriatic arthritis.
Salvarani C, Cantini F, Olivieri I, Macchioni P, Padula A, Niccoli L, Catanoso MG, Scocco GL, Boiardi L. Salvarani C, et al. Arthritis Rheum. 2003 Aug 15;49(4):541-5. doi: 10.1002/art.11201. Arthritis Rheum. 2003. PMID: 12910561 Free article. Clinical Trial.
Vascular endothelial growth factor gene polymorphisms in Behçet's disease.
Salvarani C, Boiardi L, Casali B, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Nicoli D, Farnetti E, Chen Q, Pulsatelli L. Salvarani C, et al. J Rheumatol. 2004 Sep;31(9):1785-9. J Rheumatol. 2004. PMID: 15338501
New approaches in the treatment of Adamantiades-Behçet's disease.
Pipitone N, Olivieri I, Cantini F, Triolo G, Salvarani C. Pipitone N, et al. Among authors: salvarani c. Curr Opin Rheumatol. 2006 Jan;18(1):3-9. doi: 10.1097/01.bor.0000197995.27579.9b. Curr Opin Rheumatol. 2006. PMID: 16344613 Review.
Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.
Cantini F, Niccoli L, Benucci M, Chindamo D, Nannini C, Olivieri I, Padula A, Salvarani C. Cantini F, et al. Among authors: salvarani c. Arthritis Rheum. 2006 Oct 15;55(5):812-6. doi: 10.1002/art.22236. Arthritis Rheum. 2006. PMID: 17013842 Free article. Clinical Trial. No abstract available.
812 results